Mentions in press and media 14
| Date | Title | Description |
| 06.05.2026 | MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (AR... | GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II c... |
| 24.04.2026 | Enlighten Clinical Solutions to Present at Eyecelerator@ARVO | Enlighten Clinical Solutions selected as a Presenting Company for Eyecelerator @ ARVO 2026. CEO Jim Harris will present and highlight the company’s connected clinical trial platform” — Ellie BrightmanATLANTA, GA, UNITED STATES, April 24, 20... |
| 27.05.2024 | Revolutionizing Eye Treatment: The Future of Non-Invasive Therapy | The recent presentation at ARVO 2024 by PharmAbcine's U.S. subsidiary, Wincal Biopharm, has sparked excitement in the medical community. Their innovative eye drop formulations have shown promising results in animal studies, potentially chan... |
| 23.05.2024 | PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024 | Presentation at ARVO 2024 gained attention as Eylea (aflibercept) eye drops demonstrated similar efficacy to intravitreal injections in animal studies. DAEJEON, South Korea, May 23, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine&... |
| 22.05.2024 | PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024 | Presentation at ARVO 2024 gained attention as Eylea (aflibercept) eye drops demonstrated similar efficacy to intravitreal injections in animal studies. DAEJEON, South Korea , May 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine... |
| 03.05.2024 | Phoenix-Micron Announces New Animal Stand with Integrated Anesthesia Delivery | Phoenix- Micron announces new animal stand Designed for use with inhalation anesthetics like isoflurane, the new patent-pending animal stand is designed to simplify and improve in vivo small animal ocular imaging BEND, Ore., May 3, 2024 /PR... |
| 03.05.2024 | Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024 | Company to present, across eight data presentations, new real-world research on the economic value of genetic testing for retinal diseases and the role of automatic deep-learning based algorithms for geographic atrophy Johnson & Johnson... |
| 01.05.2024 | Prevent Blindness to Host 13th Annual Focus on Eye Health Summit, a Two-Day Virtual Interactive Event, with theme of "Being Seen and Heard" | Registration open for free 13th Annual Prevent Blindness Focus on Eye Health Summit, held virtually, July 10 and 11, 2024. National nonprofit Prevent Blindness to hold the 2024 Focus on Eye Health Summit, a free virtual interactive event, J... |
| 30.04.2024 | Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific ... | SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Eluminex Biosciences (Eluminex), a privately-held biotechnology company focused on the development of advanced protein therapeutics for vision-threatening diseases and dermal f... |
| 23.04.2024 | Phoenix-Micron Enhances OCT Imaging with AI-powered OCT Segmentation | Phoenix-Micron, Inc. and ArtiKode Intelligence Collaborate to Bring Automated, AI-Powered OCT Segmentation to MICRON Software Suite BEND, Ore., April 23, 2024 /PRNewswire-PRWeb/ -- Phoenix-Micron, Inc. ("Phoenix"), recognized glob... |
Show more